Watch Ticker

Anavex Life Sciences

Go to Anavex Life Sciences Website

$4.43

(%)
Live
Previous Close

$4.43

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$375.0 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from cl...

Community
  • 0 posts discussing
0

Watchers

0

Visitors

Recent News

Anavex Life Sciences (AVXL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Related tickers: AVXL.

Read Full Article

NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental and neuropsychiatric disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome, schizophrenia, and other central nervous system (CNS) diseases, today announced that Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex, will participate in a fireside chat at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ being held May 20th, 2024 at 10:00am ET at NASDAQ World Headquarters New York City.

Related tickers: AVXL.

Read Full Article
Trending Tickers
FLGC

XNAS

$1.23
(%)
IBIT

XNAS

$39.97
(%)
LASE

XNAS

$2.28
(%)
MGAM

XNAS

$0.02
(%)
MLGO

XNAS

$0.00
(%)